| Abstrakt: |
The study aims to develop a noble biomaterial that can accelerate the healing process without the risk of infection by loading tetracycline hydrochloride and collagen hemostatic agent into the chitosan tissue scaffold. After the trials, a good tissue scaffold was obtained from chitosan and PVA by electro-spinning. To increase the hemostatic features of this biomaterial, a 10% (by weight) collagen hemostatic agent was added to the PVA chitosan blend. After the amount of collagen hemostatic agent in the chitosan tissue scaffold was set, various amounts of tetracycline were added and 5 different biomaterials were developed to augment the antibacterial and wound healing properties. Antibiotic concentration in the biomaterial was IV 10% in the first, 15% in the second, 20% in the third, 25% in the fourth, and 30% in the fifth sample. Finally, the effects of the obtained biomaterials on the nosocomial bacteria (gram-positive: Staphylococcus Aureus, gram-negative: Pseudomonas Aeruginosa) were analyzed with in-vitro tests at Kahramanmaras Sutcu Imam University, School of Medicine Department of Microbiology laboratories. As a result of the examination, it was examined how much the biomaterial should be and how effective it was against bacterial growth on the first, third, and fifth days. It is thought that the biomaterial material will be very effective in emergencies and surgical procedures. [ABSTRACT FROM AUTHOR] |
